-
Posted by
Two Blokes Jul 4 -
Filed in
Stock
-
2 views
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLPĀ reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025. Sarepta is a commercial-stage biopharmaceutical company that focuses on RNA and gene therapies for the treatment of rare diseases.